FEB 26, 2018 08:04 AM PST

Rare Immune Cells Prevent Cancer from Spreading

WRITTEN BY: Kara Marker

Cancer metastasis, the spreading of tumors to different tissues in the body, is usually what makes cancer so lethal and difficult to treat. But scientists have now identified a rare immune cell that, when injected, could prevent metastasis. A new study from the University of British Columbia shows how this is possible.

A group of killer T cells (green and red) surrounding a cancer cell (blue, center). Killer T cells use special chemicals to kill cancer cells. Credit: National Institutes of Health

The trials and tribulations of cancer immunotherapy, a treatment approach based on boosting the immune system to fight cancer, are well-known to scientists studying cancer and the immune system’s role in defeating it. Immunotherapy has been shown to be effective in blood-borne cancer types, like lymphoma, but less effective in treating solid tumors.

Why do we need immunotherapy? Why can’t the immune system naturally fight off cancer on its own? Tumors tend to “hide” from the immune system. Some can do so because they lack a protein called interleukin-33 (IL-33), allowing cancer cells to proliferate and metastasize freely, uninhibited by an immune attack.

However, a new finding may help scientists shine a light on the dark corners of the body infested with growing tumors. IL-33 normally activates cells called type-2 innate lymphoid cells (ILC2). And although some cancers lack IL-33, scientists can activate ILC2 cells manually to treat cancer.

Innate lymphoid cells were only first discovered in 2008. Scientists studying asthma identified type-2 innate lymphoid cells specifically. Uniquely, these cells do not require activation by cancer antigens, like other cells of the immune system. This means that scientists could inject ILC2 cells without needing to alter them in the lab first.

In the new study, researchers examined mice models of lung cancer, genetically altered to lack ILC2 cells. Would tumors grow faster in ILC2-deficient mice, compared to control mice with normal levels of the immune cell? They did, but even more noticeable was the rate of metastasis in the ILC2-deficient mice compared to the control mice; in mice without ILC2, tumors spread all over the body.

"These results raise the possibility that harnessing the immune system to fight cancer might be a matter of more effectively triggering ILC2 cells with IL-33, or simply having more ILC2 cells - or perhaps a combination of both," explained study leader Wilf Jefferies.

Going forward, Jefferies and his team plan to investigate if injecting mice with ILC2 will inhibit metastasis. The study and other builds a foundation for future clinical trials with ILC2 injections for human cancer patients.

The present study was published in the journal Scientific Reports.

Sources: Nature Immunology, University of British Columbia, American Cancer Society

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 23, 2018
Immunology
JUL 23, 2018
Obesity Associated Inflammation Leads to Chronic Health Issues
Inflammation caused by harmful oxidized lipids increases in individuals with obesity and may contribute to chronic disease development....
AUG 08, 2018
Immunology
AUG 08, 2018
Doxorubicin Causes Heart Toxicity by Immune System Disruption
Chemotherapy drug Doxorubicin disrupts metabolism that controls immune responses in the heart leading to heart toxicity....
SEP 10, 2018
Immunology
SEP 10, 2018
The Immune System: A New Hope for Opioid Addiction?
Addiction, Immunology, Opioid...
OCT 10, 2018
Microbiology
OCT 10, 2018
It's Time for Your Annual Flu Shot
After last year's flu season killed around 80,000 people, the CDC is trying to get the word out about the flu vaccine....
OCT 23, 2018
Immunology
OCT 23, 2018
Missense Immune Disruption
A point mutation has caused a de novo immune deficiency observed in two patients...
NOV 16, 2018
Technology
NOV 16, 2018
Novel 'Cellphone' Technology Detects HIV
Human immunodeficiency virus 1 (HIV), weakens the immune system by attacking healthy cells. Currently, the management of HIV remains a major global health ...
Loading Comments...